Carmell Therapeutics to Launch Phase III Study of Bone Healing Accelerant
Carmell Therapeutics will launch a Phase III clinical study for Bone Healing Accelerant, its first Plasma-based Bioactive Material product/indication, designed to treat fractures. May 09, 2017